Left to right_Allen Law, COO & Dr Su Wei Xin, Group Consultant of Stemcell First Group
Kuala Lumpur, April 09, 2025 — Stemcell First Group has launched a groundbreaking Multiple Cancer Early Detection (MCED) blood test, capable of identifying over 50 types of cancer, including breast, lung, and pancreatic, at their earliest stages—often years before symptoms.
Priced at RM3,888 (down from RM4,888), the test is now available at Masayo Clinic in Kuala Lumpur, SCF Clinic in Bangkok, and soon at Vanfo Hino Ambulatory Care Centre in Johor Bahru.
“Early detection is a right for all,” said COO Allen Law. The initiative aims to make cancer screening routine across Southeast Asia, improving survival rates.
Read More News on Business News Malaysia
Read More News on Business News Malaysia
CIMB Group appointed Mak Joon Nien as CEO of Growth Markets and CEO of CIMB…
Pavilion REIT posts higher Q1 2026 DPU at 2.80 sen, supported by stronger net property…
In 2026, we expect Malaysia’s economy will grow at +4.2%, underpinned by continued expansion in domestic…
Tambadana, a Malaysian financing company, enhances customer loyalty through engaging seasonal campaigns, promoting financial literacy…
PNB appoints Rizal Rickman Ramli as new President & Group CEO, succeeding Dato’ Abdul Rahman…
AMD unveiled MRC to strengthen AI networking. The protocol ensures GPUs stay synchronized under real‑world…
This website uses cookies.